Pancreatic Cancer Research

ResearcherDalian Medical UniversityActive in the last 2 years

Yu Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0784-2273; OpenAlex author ID A5101431074. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Carfilzomib relieves pancreatitis-initiated pancreatic ductal adenocarcinoma by inhibiting high-temperature requirement protein A1. Co-author DOI 10.1038/s41420-024-01806-w↗
  2. Predictive Factors for Differentiating Pancreatic Cancer-Associated Diabetes Mellitus from Common Type 2 Diabetes Mellitus for the Early Detection of Pancreati… Last author DOI 10.1159/000489169↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hong Xiang · 1 shared paper, 2024 · strength 0.24
  2. Fangyue Guo · 1 shared paper, 2024 · strength 0.24
  3. Xufeng Tao · 1 shared paper, 2024 · strength 0.24
  4. Deshi Dong · 1 shared paper, 2024 · strength 0.24
  5. Dong Shang · 1 shared paper, 2024 · strength 0.24
  6. Xin Dong · 1 shared paper, 2018 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.